#NEWS: The U.S. FDA has approved our new treatment for patients 12 and older with moderate to severe plaque psoriasis, bringing a fundamentally different systemic treatment option to patients and physicians.

Learn more: social.jnj.com/3NlAPK5

For U.S. Audience Only